IP Library Granted Patent US 9,421,133
Granted Patent B2
US 9,421,133 · App. 14/484,578 · Granted Aug 23, 2016

Closed incision negative pressure wound therapy device and methods of use

Inventors: Dean Hu (Sunnyvale, CA); Moshe Pinto (Sunnyvale, CA); Kenton Fong (Sunnyvale, CA); Akshay Mavani (Sunnyvale, CA); Kenneth Wu (Sunnyvale, CA)
Assignee: KCI Licensing, Inc.
A61F13/0226A61F13/00063A61F13/02A61F13/0216A61F13/0266A61M1/0088A61M27/00A61M35/00A61F13/00068A61F2013/00174A61F2013/00536
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,421,133
App. No.
14/484,578
Granted
Aug 23, 2016
Kind
B2
Abstract

A surgical tissue therapy device includes a sealant layer and a collection chamber. The sealant layer functions so as to create a sealed enclosure or space between it and the surface of a patient by forming, preferably, an airtight seal around a surgical area of skin trauma. The closed incision tissue therapy device also comprises a collection chamber, which may comprise an elongate tubular chamber with a plurality of longitudinally spaced openings. The collection chamber may be configured to be in fluid communication with the sealant layer and the area of skin trauma and functions as to distribute the negative pressure applied to a surgically closed area of skin trauma. Preferably, the pressure under the sealant layer is reduced by expanding the volume of the enclosure space and thereby decreasing the density of air molecules under the sealant layer. The collection material may comprise a material and/or a configuration that permits length changes based upon the length of the corresponding surgical wound or incision.

Claims (26)

1. A device to treat an area of skin trauma, the device comprising:

(a) a first material layer configured to:

seal to the area of skin trauma and,

form a sealed space around at least a portion of the area of skin trauma;

(b) a second material layer positioned beneath the first material layer to receive direct contact with the area of skin trauma; and

(c) an elastic element configured to

attach to the area of skin trauma while in a state of tension so that the elastic element extends across and over a longitudinal axis of the area of skin trauma, and

compress the area of skin trauma when attached to the area of skin trauma.

2. The device of claim 1 , further comprising a suction source configured to communicate fluid with the sealed space and reduce a level of pressure inside the sealed space.

3. The device of claim 1 , wherein the second material layer comprises a plurality of openings, and wherein the plurality of openings are configured to communicate fluid between the second material layer and the area of skin trauma.

4. The device of claim 1 , further comprising a one-way flow valve configured to facilitate an evacuation of the sealed space.

5. The device of claim 4 , wherein the one-way flow valve is configured to facilitate emptying of the sealed space.

6. The device of claim 1 , wherein the second material layer is configured to deliver one or more agents that improve a healing process.

7. The device of claim 1 , wherein at least one of the second material layer or the first material layer includes at least one of silver, silver alloy, iodine, or chlorhexidine.

8. The device of claim 7 , wherein the second material layer is a porous dressing interface.

9. The device of claim 1 , wherein the second material layer is configured to conform to a length of the area of skin trauma.

10. The device of claim 1 , wherein the first material layer is configured to conform to a length of the area of skin trauma.

11. The device of claim 1 , wherein the first material layer is semi-rigid.

12. The device of claim 1 , wherein the first material layer is configured to provide tensile support to the area of skin trauma to alleviate mechanical tension.

13. The device of claim 1 , wherein the device further comprises one or more absorbent beads configured to absorb fluid at the area of skin trauma.

14. The device of claim 1 , wherein the first material layer is further configured to deliver one or more antimicrobial agents to the area of skin trauma.

15. The device of claim 1 , wherein the device is configured to deliver reduced pressure between about 0.001 to about 1 atmosphere at the area of skin trauma.

16. The device of claim 1 , wherein the first material layer comprises a hydrocolloid material.

17. The device of claim 16 , wherein the first material layer is configured to protect the area of skin trauma and prevent a trapping of fluid under the device.

18. The device of claim 1 , wherein the first material layer further comprises a release liner coupled to a lower surface of the first material layer.

19. The device of claim 18 , wherein the first material layer and release liner are in a rolled configuration and are configured to dispense and separate from each other as the first material layer seals to the area of skin trauma.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066445/0336 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064730/0636 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2015
From: SPIRACUR INC.
To: KCI LICENSING, INC.
Reel/Frame 037355/0210 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2015
From: HU, DEAN; PINTO, MOSHE; FONG, KENTON; MAVANI, AKSHAY; WU, KENNETH
To: SPIRACUR INC.
Reel/Frame 035625/0462 →
Continuity (5)
Continuation 14058175 · Oct 18, 2013
Continuation 13004819 · Jan 11, 2011
Continuation 12249759 · Oct 10, 2008
Provisional Application 60979315 · Oct 11, 2007
Related Publication 20150005722A1 · Jan 1, 2015